Effect of ligand binding on human D-amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment

Protein Science

Volumn 19, Issue 8, 2010, Pages 1500-1512

  Caldinelli, Laura ^a,b   Molla, Gianluca ^a,b   Bracci, Luisa ^c   Lelli, Barbara ^c   Pileri, Silvia ^c   Cappelletti, Pamela ^a,b   Sacchi, Silvia ^a,b   Pollegioni, Loredano ^a,b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b POLITECNICO DI MILANO   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

D serine; Flavoproteins; Folding; Ligand binding; Schizophrenia

Indexed keywords

APOPROTEIN; BENZOIC ACID; CHLORPROMAZINE; DEXTRO AMINO ACID OXIDASE; DEXTRO SERINE; FLAVOPROTEIN; HOLOENZYME; SERINE;

ARTICLE; CANCER CELL CULTURE; ENZYME STRUCTURE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN STABILITY; SCHIZOPHRENIA; THERMOSTABILITY;

ANTIPSYCHOTIC AGENTS; BENZOIC ACIDS; CHLORPROMAZINE; D-AMINO-ACID OXIDASE; DRUG DESIGN; ENZYME STABILITY; FLAVIN-ADENINE DINUCLEOTIDE; HUMANS; LIGANDS; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; SCHIZOPHRENIA; SERINE;

TRIFLUORO;

EID: 77955102371     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.429     Document Type: Article

References (22)

1. Pollegioni L, Piubelli L, Sacchi S, Pilone MS, Molla G (2007) Physiological functions of D-amino acid oxidases: from yeast to humans. Cell Mol Life Sci 64:1373-1394. (Pubitemid 46889231)
2. Oliet SH, Mothet JP (2009) Regulation of N-methyl-D-aspartate receptors by astrocytic D-serine. Neuroscience 158:275-283.
3. Pollegioni L, Sacchi S (in press) Metabolism of the neuromodulator D-serine. Cell Mol Life Sci.
4. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10:40-68. (Pubitemid 40139588)
5. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT (2006) Neurobiology of schizophrenia. Neuron 52: 139-153.
6. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, Bougueleret L, Barry C, Tanaka H, La Rosa P, Puech A, Tahri N, Cohen-Akenine A, Delabrosse S, Lissarrague S, Picard FP, Maurice K, Essioux L, Millasseau P, Grel P, Debailleul V, Simon AM, Caterina D, Dufaure I, Malekzadeh K, Belova M, Luan JJ, Bouillot M, Sambucy JL, Primas G, Saumier M, Boubkiri N, Martin-Saumier S, Nasroune M, Peixoto H, Delaye A, Pinchot V, Bastucci M, Guillou S, Chevillon M, Sainz-Fuertes R, Meguenni S, Aurich-Costa J, Cherif D, Gimalac A, Van Duijn C, Gauvreau D, Ouellette G, Fortier I, Raelson J, Sherbatich T, Riazanskaia N, Rogaev E, Raeymaekers P, Aerssens J, Konings F, Luyten W, Macciardi F, Sham PC, Straub RE, Weinberger DR, Cohen N, Cohen D (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99: 13675-13680.
7. Molla G, Sacchi S, Bernasconi M, Pilone MS, Fukui K, Pollegioni L (2006) Characterization of human D-amino acid oxidase. FEBS Lett 580:2358-2364.
8. Molla G, Bernasconi M, Sacchi S, Pilone MS, Pollegioni L (2006) Expression in Escherichia coli and in vitro refolding of the human protein pLG72. Protein Expr Purif 46:150-155. (Pubitemid 43247008)
9. Sacchi S, Bernasconi M, Martineau M, Mothet JP, Ruzzene M, Pilone MS, Pollegioni L, Molla G (2008) pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility. J Biol Chem 283:22244-22256.
10. Adage T, Trillat AC, Quattropani A, Perrin D, Cavarec L, Shaw J, Guerassimenko O, Giachetti C, Gréco B, Chumakov I, Halazy S, Roach A, Zaratin P (2008) In vitro and in vivo pharmacological profile of AS057278, a selective D-amino acid oxidase inhibitor with potential anti-psychotic properties. Eur Neuropsychopharmacol 18:200-214.
11. Sparey T, Abeywickrema P, Almond S, Brandon N, Byrne N, Campbell A, Hutson PH, Jacobson M, Jones B, Munshi S, Pascarella D, Pike A, Prasad GS, Sachs N, Sakatis M, Sardana V, Venkatraman S, Young MB (2008) The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors. Bioorg Med Chem Lett 18:3386-3391.
12. Ferraris D, Duvall B, Ko YS, Thomas AG, Rojas C, Majer P, Hashimoto K, Tsukamoto T (2008) Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem 51:3357-3359.
13. Duplantier AJ, Becker SL, Bohanon MJ, Borzilleri KA, Chrunyk BA, Downs JT, Hu LY, El-Kattan A, James LC, Liu S, Lu J, Maklad N, Mansour MN, Mente S, Piotrowski MA, Sakya SM, Sheehan S, Steyn SJ, Strick CA, Williams VA, Zhang L (2009) Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)- one series of potent D-amino acid oxidase (DAAO) inhibitors. J Med Chem 52:3576-3585.
14. Spector R (1980) Riboflavin homeostasis in the central nervous system. J Neurochem 35:202-209. (Pubitemid 10063224)
15. Caldinelli L, Molla G, Sacchi S, Pilone MS, Pollegioni L (2009) Relevance of weak flavin binding in human D-amino acid oxidase. Protein Sci 18:801-810.
16. Kawazoe T, Tsuge H, Pilone MS, Fukui K (2006) Crystal structure of human D-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci 15:2708-2717.
17. Iwana S, Kawazoe T, Park HK, Tsuchiya K, Ono K, Yorita K, Sakai T, Kusumi T, Fukui K (2008) Chlorpromazine oligomer is a potentially active substance that inhibits human D-amino acid oxidase, product of a susceptibility gene for schizophrenia. J Enzyme Inhib Med Chem 23:901-911.
18. Umhau S, Pollegioni L, Molla G, Diederichs K, Welte W, Pilone MS, Ghisla S (2000) The x-ray structure of D-amino acid oxidase at very high resolution identifies the chemical mechanism of flavin-dependent substrate dehydrogenation. Proc Natl Acad Sci USA 97:12463-12468.
19. Hubbard SJ (1998) The structural aspects of limited proteolysis of native proteins. Biochim Biophys Acta 1382:191-206.
20. Karlsson R, Jendeberg L, Nilsson B, Nilsson J, Nygren PA (1995) Direct and competitive kinetic analysis of the interaction between human IgG1 and a one domain analogue of protein A. J Immunol Methods 183:43-49.
21. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20:687-702.
22. Tsai G, Van Kammen DP, Chen S, Kelley ME, Grier A, Coyle JT (1998) Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia. Biol Psychiatry 44:667-674. (Pubitemid 28496781)